LUNESTA Safety Questions, LUNESTA Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about LUNESTA. Our extensive database of LUNESTA adverse events and LUNESTA warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about LUNESTA

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet



LUNESTA Safety Reports

Total LUNESTA reports: 3605.
LUNESTA FDA safety alerts: 2007 .
Reported deaths: 15    Reported hospitalizations: 67.
Take LUNESTA Side Effects Survey or Share Your LUNESTA Story. LUNESTA Usage.

Showing 1-75 of 3605 Next >

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Dec 14, 2006. Male patient, 69 years of age, weighting 175.0 lb, was diagnosed with initial insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: middle insomnia. LUNESTA dosage: 2 MG;HS;ORAL. During the same period patient was treated with COSOPT, XALATAN, AMBIEN. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 14, 2006. Female patient was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dysgeusia. LUNESTA dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Dec 14, 2006. Female patient was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: insomnia. LUNESTA dosage: unknown. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 15, 2006. Male patient, 69 years of age, was diagnosed with sleep disorder and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dysgeusia. LUNESTA dosage: 3 MG;QD;ORAL. During the same period patient was treated with HYDROCHLOROTHIAZIDE, NADOLOL, ALTACE, VYTORIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Oct 16, 2006. Female patient, 35 years of age, weighting 116.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: herpes zoster. LUNESTA dosage: unknown. During the same period patient was treated with DOXYCYCLINE, ORAL CONTRACEPTIVE NOS. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 16, 2006. Male patient, 62 years of age, weighting 275.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dizziness, initial insomnia, yawning. LUNESTA dosage: 3 MG;HS;ORAL. During the same period patient was treated with METFORMIN, SOTALOL HYDROCHLORIDE, FEXOFENADINE, GLYBURIDE, ACIPHEX, PAROXETINE, COZAAR, ALLOPURINOL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Oct 16, 2006. Female patient, 58 years of age, weighting 178.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dysgeusia, middle insomnia. LUNESTA dosage: unknown. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 16, 2006. Male patient, 49 years of age, weighting 211.0 lb, was diagnosed with restless legs syndrome and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: insomnia. LUNESTA dosage: 3 MG;ORAL. During the same period patient was treated with REQUIP. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Oct 16, 2006. Female patient, 51 years of age, weighting 230.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dizziness, dysgeusia, insomnia. LUNESTA dosage: 3 MG;PRN;ORAL. During the same period patient was treated with PAMELOR, KLONOPIN, YASMIN, VALSARTAN, EFFEXOR. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 17, 2006. Female patient, 42 years of age, weighting 130.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: migraine. LUNESTA dosage: 2 MG;HS;ORAL. During the same period patient was treated with CLARITIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Oct 16, 2006. Female patient, 30 years of age, weighting 115.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: insomnia. LUNESTA dosage: 2 MG;HS;ORAL. During the same period patient was treated with EFFEXOR, ATIVAN. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 17, 2006. Female patient, 55 years of age, weighting 125.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: alopecia. LUNESTA dosage: unknown. During the same period patient was treated with VITAMINS. Patient recovered.

Health Professional from UNITED STATES reported LUNESTA problem on Oct 16, 2006. Female patient was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: suicidal ideation. LUNESTA dosage: 3 MG;ORAL. During the same period patient was treated with ZOLOFT. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 17, 2006. Female patient, 42 years of age, weighting 105.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: alopecia, middle insomnia. LUNESTA dosage: unknown. During the same period patient was treated with AMBIEN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Oct 17, 2006. Female patient, 66 years of age, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: fatigue, insomnia, poor quality sleep. LUNESTA dosage: unknown. During the same period patient was treated with SEROQUEL, ZOLOFT, TOPAMAX, NEXIUM, SYNTHROID, VALSARTAN, VYTORIN. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 13, 2006. Male patient, weighting 190.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dysgeusia. LUNESTA dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Oct 13, 2006. Female patient, 87 years of age, was diagnosed with insomnia, depression and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: fatigue. LUNESTA dosage: unknown. During the same period patient was treated with LEXAPRO, NEURONTIN, XANAX, AMLODIPINE, ZESTRIL, VITAMIN CAP. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 17, 2006. Female patient was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dysgeusia. LUNESTA dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Oct 17, 2006. Female patient, 46 years of age, weighting 110.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: insomnia. LUNESTA dosage: unknown. During the same period patient was treated with TEMAZEPAM, FLEXERIL, IBUPROFEN, ZOLOFT, XOPENEX HFA INHALATION AEROSOL, ATROVENT, PANTOPRAZOLE. Patient recovered.

LUNESTA problem was reported by a Health Professional from UNITED STATES on Oct 17, 2006. Male patient was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dysgeusia, zinc deficiency. LUNESTA dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Oct 17, 2006. Female patient was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: insomnia. LUNESTA dosage: 3 MG;ORAL. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 17, 2006. Female patient, 55 years of age, weighting 160.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: insomnia. LUNESTA dosage: 2 MG;ORAL. During the same period patient was treated with PLAQUENIL, SYNTHROID, CELEXA, ACIPHEX, VITAMINS, MINERALS NOS, MAGNESIUM. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Oct 17, 2006. Female patient, 63 years of age, weighting 145.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: initial insomnia. LUNESTA dosage: 3 MG;HS;ORAL. During the same period patient was treated with GLUCOPHAGE, GLUCOTROL, HYDROCHLOROTHIAZIDE, AVAPRO, AMLODIPINE BESYLATE. Patient recovered.

LUNESTA problem was reported by a Physician from UNITED STATES on Oct 11, 2006. Female patient was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: insomnia. LUNESTA dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Oct 13, 2006. Female patient, 62 years of age, weighting 194.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: oral pain, tongue blistering. LUNESTA dosage: 2 MG;HS;ORAL. During the same period patient was treated with NEURONTIN, LEVOTHYROXINE, CALCIUM, VITAMINUM B. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2006. Male patient was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dysgeusia. LUNESTA dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Oct 13, 2006. Male patient, 47 years of age, weighting 180.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dysgeusia. LUNESTA dosage: unknown. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 13, 2006. Male patient, 61 years of age, weighting 183.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: middle insomnia, psychiatric symptom, suicidal ideation. LUNESTA dosage: 2 MG;HS;ORAL. During the same period patient was treated with PAXIL, LOVASTATIN. Patient recovered.

Physician from UNITED STATES reported LUNESTA problem on Oct 13, 2006. Female patient, 44 years of age, weighting 107.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: insomnia. LUNESTA dosage: unknown. During the same period patient was treated with CYMBALTA, ESTROGENS SOL. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 16, 2006. Female patient, 62 years of age, weighting 194.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: insomnia. LUNESTA dosage: 3 MG;HS;ORAL. During the same period patient was treated with ALTACE, COREG, PLAVIX, PENTOXIFYLLINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Oct 16, 2006. Male patient, 89 years of age, weighting 135.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: middle insomnia. LUNESTA dosage: 3 MG;HS;ORAL. During the same period patient was treated with EYE DROPS, SYNTHROID, VITAMIN CAP. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 16, 2006. Female patient, 80 years of age, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dysgeusia, insomnia. LUNESTA dosage: unknown. During the same period patient was treated with ATORVASTATIN CALCIUM, FOSAMAX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Oct 13, 2006. Male patient, 61 years of age, weighting 225.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dry mouth, dysgeusia, pollakiuria. LUNESTA dosage: unknown. During the same period patient was treated with VICODIN, WARFARIN, DIOVAN, CALCIUM, GARLIC, VITAMIN CAP. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 08, 2006. Female patient, 76 years of age, weighting 160.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dysgeusia, middle insomnia. LUNESTA dosage: 3 MG;1X;ORAL. During the same period patient was treated with GLUCOPHAGE, GLYBURIDE. Patient recovered.

Health Professional from UNITED STATES reported LUNESTA problem on Nov 07, 2006. Female patient was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: amnesia. LUNESTA dosage: 3 MG;ORAL. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 08, 2006. Male patient, 70 years of age, weighting 198.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dysgeusia, middle insomnia. LUNESTA dosage: 2 MG;HS;ORAL. During the same period patient was treated with MICARDIS, AMLODIPINE, ASPIRIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Oct 03, 2006. Female patient, 58 years of age, weighting 160.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dysgeusia, insomnia. LUNESTA dosage: 3 MG;ORAL. Patient recovered.

LUNESTA problem was reported by a Health Professional from UNITED STATES on Nov 07, 2006. Female patient, 48 years of age, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: insomnia. LUNESTA dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Nov 08, 2006. Female patient, 47 years of age, weighting 270.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: diarrhoea. LUNESTA dosage: 3 MG;HS;ORAL. During the same period patient was treated with DIURETICS. Patient recovered.

LUNESTA problem was reported by a Health Professional from UNITED STATES on Nov 07, 2006. Male patient was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: insomnia, pruritus. LUNESTA dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported LUNESTA problem on Nov 07, 2006. Female patient was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: middle insomnia, nightmare. LUNESTA dosage: 2 MG;ORAL. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 08, 2006. Female patient, 54 years of age, weighting 160.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dyspnoea, somnolence. LUNESTA dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Nov 08, 2006. Male patient was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper. LUNESTA dosage: unknown. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 09, 2006. Female patient, 57 years of age, weighting 165.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dysgeusia. LUNESTA dosage: unknown. During the same period patient was treated with ESCITALOPRAM, SIMVASTATIN, ESOMEPRAZOLE MAGNESIUM. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Nov 09, 2006. Female patient, 60 years of age, weighting 184.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: anxiety, blood glucose increased, heart rate irregular. LUNESTA dosage: unknown. During the same period patient was treated with VALSARTAN, FOLIC ACID, PIOGLITAZONE, OMEPRAZOLE, SIMVASTATIN, ASPIRIN, METFORMIN. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 09, 2006. Female patient, 80 years of age, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: middle insomnia. LUNESTA dosage: unknown. During the same period patient was treated with LISINOPRIL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Nov 08, 2006. Female patient, 68 years of age, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dysgeusia. LUNESTA dosage: 3 MG;ORAL. During the same period patient was treated with TYLENOL. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 09, 2006. Female patient, 69 years of age, weighting 150.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: middle insomnia. LUNESTA dosage: 3 MG;PRN;ORAL. During the same period patient was treated with PLENDIL, ACTONEL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Nov 08, 2006. Male patient, 56 years of age, weighting 150.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: initial insomnia. LUNESTA dosage: 2 MG;HS;ORAL. During the same period patient was treated with TAMSULOSIN, DIPHENHYDRAMINE HYDROCHLORIDE, MUSCLE RELAXANTS, AMITRIPTYLINE. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 09, 2006. Female patient, 54 years of age, weighting 140.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dysgeusia, initial insomnia. LUNESTA dosage: 3 MG;HS;ORAL. During the same period patient was treated with LEVOTHYROXINE. Patient recovered.

Physician from UNITED STATES reported LUNESTA problem on Nov 09, 2006. Female patient was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dysgeusia. LUNESTA dosage: 3 MG;ORAL. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 09, 2006. Male patient, 66 years of age, weighting 180.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: insomnia, malaise, somnolence. LUNESTA dosage: unknown. During the same period patient was treated with INTERFERON, REQUIP, VALSARTAN, VYTORIN, AMBIEN, HALCION. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Nov 10, 2006. Female patient, 63 years of age, weighting 130.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: headache, initial insomnia, neck pain. LUNESTA dosage: 2 MG;ORAL. During the same period patient was treated with VICODIN, ADVIL, DIPHENHYDRAMINE, PANTOPRAZOLE, ALBUTEROL. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 02, 2006. Male patient, 70 years of age, weighting 185.0 lb, was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: middle insomnia. LUNESTA dosage: 3 MG;ORAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Dec 03, 2006. Female patient was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dysgeusia. LUNESTA dosage: unknown. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 03, 2006. Female patient, 72 years of age, weighting 145.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dysgeusia, initial insomnia. LUNESTA dosage: 2 MG;HS;ORAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Dec 03, 2006. Female patient, 69 years of age, weighting 140.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dysgeusia. LUNESTA dosage: unknown. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 04, 2006. Female patient, 93 years of age, weighting 112.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: somnolence. LUNESTA dosage: 2 MG;1X;ORAL. During the same period patient was treated with AMLODIPINE, GLYCERYL TRINITRATE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Dec 04, 2006. Female patient, 85 years of age, weighting 145.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: insomnia. LUNESTA dosage: 2 MG;1X;ORAL. During the same period patient was treated with AMBIEN. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 04, 2006. Male patient, 59 years of age, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dysgeusia. LUNESTA dosage: 3 MG;ORAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Dec 04, 2006. Male patient, 80 years of age, weighting 190.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: middle insomnia. LUNESTA dosage: 3 MG;ORAL. During the same period patient was treated with AMBIEN, BUMEX, WATER S, POTASSIUM ACETATE, LANOXIN. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 04, 2006. Male patient, 70 years of age, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dysgeusia. LUNESTA dosage: unknown. During the same period patient was treated with AMBIEN, ALTACE, ATENOLOL, AVODART, TAMSULOSIN, ATORVASTATIN CALCIUM, ASPIRIN. Patient recovered.

Physician from UNITED STATES reported LUNESTA problem on Nov 30, 2006. Male patient, 53 years of age, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: insomnia. LUNESTA dosage: unknown. During the same period patient was treated with XANAX, OXYCODONE. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 06, 2006. Male patient, 23 years of age, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: middle insomnia. LUNESTA dosage: 3 MG;ORAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Dec 06, 2006. Female patient, 26 years of age, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: middle insomnia. LUNESTA dosage: 3 MG;ORAL. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 07, 2006. Male patient, 54 years of age, weighting 200.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: headache, middle insomnia. LUNESTA dosage: 2 MG;QOD;ORAL. During the same period patient was treated with OLANZAPINE, NASAL SPRAY. Patient recovered.

Physician from UNITED STATES reported LUNESTA problem on Dec 06, 2006. Female patient was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dysgeusia. LUNESTA dosage: unknown. Patient recovered.

LUNESTA problem was reported by a Physician from UNITED STATES on Dec 06, 2006. Female patient was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: hallucination. LUNESTA dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Dec 07, 2006. Male patient, 85 years of age, weighting 155.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: abnormal dreams, hallucination, insomnia. LUNESTA dosage: 1 MG;HS;ORAL. During the same period patient was treated with ATENOLOL, SPIRONOLACTONE, FUROSEMIDE, SYNTHROID. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 28, 2006. Female patient was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: initial insomnia, poor quality sleep. LUNESTA dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Dec 07, 2006. Male patient, 81 years of age, weighting 147.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dysgeusia. LUNESTA dosage: 3 MG;HS;ORAL. During the same period patient was treated with SIMVASTATIN, SINGULAIR. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 07, 2006. Female patient, 66 years of age, weighting 132.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: alopecia, hypotrichosis. LUNESTA dosage: 2 MG;ORAL. During the same period patient was treated with NEURONTIN, DESYREL, LISINOPRIL, ACIPHEX, ESTRADIOL, LEXAPRO, SIMVASTATIN, ACETYLSALICYLIC ACID SRT. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Dec 07, 2006. Female patient, 75 years of age, weighting 160.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: insomnia. LUNESTA dosage: 2 MG;HS;ORAL. During the same period patient was treated with LOPID, METFORMIN. Patient recovered.

LUNESTA problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 07, 2006. Female patient was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: hallucination, limb discomfort. LUNESTA dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LUNESTA problem on Dec 07, 2006. Female patient, 64 years of age, weighting 195.0 lb, was diagnosed with insomnia and was treated with LUNESTA. After drug was administered, patient experienced the following problems/side effects: dysgeusia. LUNESTA dosage: 3 MG;1X;ORAL. During the same period patient was treated with SONATA, NORTRIPTYLINE, MIRTAZAPINE, WELLBUTRIN, LEXAPRO. Patient recovered.

Showing 1-75 of 3605 Next >

Ask Our Patient Community about LUNESTA

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol
Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol
Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

 F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
HaloperidolThis drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant
Insulin Glulisine recombinant
Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
LinezolidThis drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant
Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus
PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil